| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate |
2003-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8364595a5ebf3a1fc8315329710f243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99227af610ab6af5124743c774b0a8ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a38aee461d830b48a401236ce2da9a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcd62e5cba92cbb6b3be967854427563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fffa026ba00a90fe2c0f955937b4b19e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f97536bb55b3cb8a073788b127fc16c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d3bbf0f9f126a36c69f251fade011e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24ebcbdff1e1187ef8a54a282a8c6fae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a9b591b916ce4fa6e6894629d1c5b2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16d5c8762344a4c829ac19236b70c3e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5340dca85d604f67b17bae37f7752f9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e61c4c7be8bef68089213c2067cc2159
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba530f0e1227b5df73e3dd2b7b8a9816 |
| publicationDate |
2003-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003162276-A1 |
| titleOfInvention |
Nucleic acid and amino acid sequences for ATP-binding cassette transporter and methods of screening for agents that modify ATP-binding cassette transporter |
| abstract |
The present invention provides nucleic acid and amino acid sequences of an ATP binding cassette transporter and mutated sequences thereof associated with macular degeneration. Methods of detecting agents that modify ATP-binding cassette transporter comprising combining purified ATP binding cassette transporter and at least one agent suspected of modifying the ATP binding cassette transporter an observing a change in at least one characteristic associated with ATP binding cassette transporter. Methods of detecting macular degeneration is also embodied by the present invention. |
| priorityDate |
1997-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |